PUBLISHER: Polaris Market Research | PRODUCT CODE: 1762470
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1762470
The global intracranial aneurysm market size is expected to reach USD 3,902.83 Million by 2034, according to a new study by Polaris Market Research. The report "Intracranial Aneurysm Market Size, Share, Trends, Industry Analysis Report: By Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, and Others), End-Use, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The intracranial aneurysm market focuses on the range of medical products and procedures used to diagnose and treat weakened, bulging blood vessels in the brain, known as intracranial or cerebral aneurysms. These aneurysms pose a significant health risk due to the possibility of rupture, which can lead to severe neurological damage, including hemorrhagic stroke and death. The market includes various diagnostic tools, such as advanced neuroimaging techniques, as well as therapeutic interventions like surgical clipping and endovascular treatments, including coil embolization and flow diversion. The primary objective of this market is to provide effective solutions for preventing aneurysm rupture and managing the consequences if a rupture occurs.
Increased awareness of cerebrovascular diseases and the availability of advanced diagnostic technologies are contributing to earlier detection of aneurysms. Additionally, the rising prevalence of risk factors such as hypertension and smoking, along with a growing aging population, is increasing the number of individuals at risk for these conditions. The market is further driven by continual advancements in medical devices and a rising preference for minimally invasive treatment options, which offer improved patient outcomes and shorter recovery times. These dynamics are shaping the development and adoption of innovative solutions within the intracranial aneurysm market.
By type, the endovascular coiling subsegment currently holds the largest market share globally. This dominance is primarily driven by the increasing preference for minimally invasive procedures and the broad applicability of coil embolization across various aneurysm characteristics.
By end-use, the hospitals subsegment accounts for the largest market share. This is due to the concentration of advanced neuroimaging and neurosurgical infrastructure in hospitals, which are essential for the diagnosis and comprehensive management of both ruptured and unruptured intracranial aneurysms.
By region, North America intracranial aneurysm market held the largest revenue share in 2024. The Asia Pacific region is witnessing the highest growth rate in the intracranial aneurysm market.
Some of the major players currently active in the intracranial aneurysm market include Medtronic plc, Stryker Corporation, Johnson & Johnson (CERENOVUS), Terumo Corporation (MicroVention Inc.), B. Braun Melsungen AG, MicroPort Scientific Corporation, Integra LifeSciences Corporation (Codman Neuro), Penumbra, Inc., Kaneka Corporation, and Phenox GmbH.
Polaris Market Research has segmented the Intracranial Aneurysm market report based on type, end-use, and region:
By Type Outlook (Revenue - USD Million, 2020-2034)
Surgical Clipping
Endovascular Coiling
Flow Diverters
Others
By End-Use Outlook (Revenue - USD Million, 2020-2034)
Hospitals
Clinics
Others
By Regional Outlook (Revenue - USD Million, 2020-2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America